|
?:authorAffiliation
|
-
[\'Jennifer E. Gerber, PhD, MSc, was a PhD Student and Graduate Research Assistant at the time of the study, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. She is now an Epidemiologist, RTI International, Washington, DC. Gail Geller, ScD, MHS, is a Professor, Department of Health, Behavior, and Society and Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health; Professor, Department of Medicine, Johns Hopkins School of Medicine; and Director of Education Initiatives and Core Faculty, Berman Institute of Bioethics, Johns Hopkins University; all in Baltimore, MD. Angie Boyce, PhD, is a Science and Technology Policy Fellow, American Association for the Advancement of Science, Washington, DC. Lisa L. Maragakis, MD, MPH, is an Associate Professor of Medicine and Executive Director, Johns Hopkins Biocontainment Unit; and Brian T. Garibaldi, MD, MEHP, is an Associate Professor of Medicine, Physiology, and Informatics, Division of Pulmonary and Critical Care, and Director, Johns Hopkins Biocontainment Unit; both in the Johns Hopkins School of Medicine, Baltimore, MD. Lisa L. Maragakis is also Senior Director of Infection Prevention, The Johns Hopkins Health System, Baltimore, MD.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}